Cargando…
Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples
INTRODUCTION: Non-invasive prenatal testing (NIPT) for aneuploidy using cell-free DNA in maternal plasma has been widely adopted. Recently, NIPT coverage has expanded to detect subchromosomal abnormalities including the 22q11.2 deletion. Validation of a SNP-based NIPT for detection of 22q11.2 deleti...
Autores principales: | Ravi, Harini, McNeill, Gabriel, Goel, Shruti, Meltzer, Steven D., Hunkapiller, Nathan, Ryan, Allison, Levy, Brynn, Demko, Zachary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825123/ https://www.ncbi.nlm.nih.gov/pubmed/29474437 http://dx.doi.org/10.1371/journal.pone.0193476 |
Ejemplares similares
-
Prenatal diagnosis of rearrangements in the fetal 22q11.2 region
por: Li, Suping, et al.
Publicado: (2020) -
Pediatric healthcare costs for patients with 22q11.2 deletion syndrome
por: Benn, Peter, et al.
Publicado: (2017) -
Incidence of the 22q11.2 deletion in a large cohort of miscarriage samples
por: Maisenbacher, Melissa K., et al.
Publicado: (2017) -
Clinical experience with single‐nucleotide polymorphism‐based non‐invasive prenatal screening for 22q11.2 deletion syndrome
por: Gross, S. J., et al.
Publicado: (2016) -
Variety of prenatally diagnosed congenital heart disease in 22q11.2 deletion syndrome
por: Lee, Mi-Young, et al.
Publicado: (2014)